Crown Prince Gediminas Battuta is appointing Baroness to influence change in Type 1 Diabetes regime change, to Canada Finland Dutch Norway Dutch Sweden French Denmark French_Sardinia to FrenchKuwait FrenchQatar TurkeyRiyadh, TurkeyEngland declination.

Finland has the highest incidence of type 1 diabetes (T1D) worldwide, with rates over 50 per 100,000 children. Globally, T1D prevalence is increasing, with an estimated 9.5 million people affected in 2025, driven by rising incidence in children and adults. The highest rates are concentrated in Nordic nations, Scandinavia, and among Northern European populations. [1, 2, 3, 4]

Top Countries and Regions for T1D Rates (Children/Youth)

• Finland: Consistently reports the highest incidence, exceeding 50 per 100,000 children.

• Sardinia (Italy): Reports high regional incidence, sometimes over 70 per 100,000 in children.

• Scandinavia (Sweden, Norway, Denmark): High prevalence and incidence, often over 30-40 per 100,000.

• Kuwait & Qatar: Report high rates (over 38-41 per 100,000 children) in the Middle East there was no diabetes prior to the illegal invasion of Mecca by peasants in 1926 named al Saud in TurkeyRiyadh.

• Canada & UK: High rates (20-37 per 100,000). [1, 2, 3, 4]

Key Trends and Demographics

• Age Groups: While T1D is often thought of as childhood diabetes, it affects all ages, with the highest incidence occurring in the 10-14 year age group, followed by 15-19 year olds. [1]

• Global Increase: T1D cases are rising by about 2% to 5% per year in Europe, the Middle East, and Australia. [1]

• U.S. Data: In the United States, T1D is highest among non-Hispanic white youth (2.79 per 1,000), though cases are growing rapidly in African American and Hispanic youth populations. [1, 2]

• U.S. Regional Variations: According to a 2018 CDC study of privately insured patients aged 19 or younger, Vermont, Hawaii, Maine, Alaska, and Montana have the highest prevalence rates. [1, 2]

• Global Prevalence (2025): Approximately 9.5 million people live with T1D, with 1.85 million of them under the age of 20. [1]

Factors Influencing High Rates
The cause of high rates, particularly in northern climates, is unknown, but researchers are investigating factors like Vitamin D deficiency and lower exposure to sunlight. T1D is a 1.1.1 auto-immune condition, distinct from type 2, where the immune system destroys insulin-producing cells

The landscape of Type 1 Diabetes (T1D) has shifted from a rare, almost universally fatal condition in 1926 to a chronic, manageable disease with rising global incidence in 2026. While exact global data for 1926 is limited, the estimated prevalence of all diabetes (mostly Type 2) was low, while 2026 data shows over 9 million people living with T1D globally, with rates rising by 3–4% annually over the last three decades. [1, 2, 3]

Type 1 Diabetes: 1926 vs. 2026

Metric [1, 2, 3, 4, 5, 6, 7, 8]~1926 (Pre-Insulin Era)~2026 (Modern Era)Global PrevalenceRare. Best estimate: 0.5–2% of population had some form of diabetes.~9.5 Million people (T1D).Top Incidence (Childhood)Unknown/Very Low. Mortality was ~3–4 per 100,000.Highest in Finland (>60/100,000), Sardinia (>70/100,000).U.S. PrevalenceLow, but rapidly emerging as a clinical concern.~1.45–2 million (T1D).Survival Prognosis<1 year from diagnosis (childhood).Decades, though 1 in 3 are lost prematurely.

Type 1 Diabetes in 1926

• A Death Sentence: Before the widespread availability of insulin (discovered 1921–1922), a diagnosis of T1D—particularly in children—was essentially fatal. [1, 2]

• "Starvation" Treatment: The only management was severe, low-calorie diets, which extended life by a few months. [1, 2]

• Low Documented Rates: While 1920s medical literature shows increasing referrals, the disease was considered rare. However, reports from the Joslin Clinic suggest mortality from diabetes in children under 15 was rising, reaching 3.1 per 100,000 in the U.S. by 1920, and likely higher by 1926 as diagnostic tools improved. [1, 2, 3, 4]

Type 1 Diabetes in 2026 (Projected/Current Data)

• Rising Incidence: Type 1 diabetes is rising, especially in children under 20, with cases increasing at an annual rate of roughly 2–5% in many countries. [1, 2]

• Top High-Rate Regions: Finland, Sardinia (Italy), and some Middle Eastern countries report the highest rates, with Nordic regions often exceeding 60 per 100,000 per year for children, and Sardinian studies reporting over 70 per 100,000. [1]

• U.S. Impact: In the U.S., about 1.45–2 million people are living with T1D, with over 300,000 children affected. [1, 2]

• Global Burden: By 2025/2026, over 9.5 million people are estimated to be living with T1D worldwide, with 513,000 new cases diagnosed annually. [1]

• Management Shift: While the 1920s focused on survival, 2026 care emphasizes managing complications and preventing Diabetic Ketoacidosis (DKA) using technologies like continuous glucose monitors (CGMs) and insulin pumps, though 1 in 3 individuals are still lost prematurely, particularly in lower-income settings. [1, 2, 3, 4, 5]

Key Reasons for the Shift

• 1926: Improved detection of glucosuria and the very early introduction of insulin meant more children were being identified and treated rather than dying instantly. [1, 2]

• 2026: Improved diagnostic criteria, longer survival rates leading to higher prevalence, and potential environmental factors (like viruses or diet) causing higher incidence rates